Record First Quarter Revenues of $22.0 million Total payment dollars processed through all payment channels up 34% versus the prior year period …
Revenue for the First Quarter Ended March 31, 2025 was $13.1 million Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) Commercial…
Generated net FUROSCIX® revenue of $11.8 million in the first quarter of 2025 Formally launched FUROSCIX in second approved indication,…
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), a…
MONTREAL, May 14, 2025 (GLOBE NEWSWIRE) -- Senvest Capital Inc. today reported a net loss attributable to common shareholders of…
MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease; Initial Data Expected in Q1 2026 MZE782 Phase 1…
The VENTANA MET (SP44) RxDx Assay detects the MET (also known as c-Met) protein, which is over-expressed in some patients…
Year-over-year Q1 revenues increase by 22% to $24.3 million71% year-over-year improvement in adjusted EBITDA in first quarterConference call with Q&A…
SAN JUAN, Puerto Rico, May 14, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) ("Red Cat" or the…
Achieved positive gross margin of approximately 20%, for the first quarter 2025LOS ANGELES, May 14, 2025 (GLOBE NEWSWIRE) -- Xos,…
This website uses cookies.